Delivering better treatments
Camurus is committed to improving the lives of patients
with severe and chronic diseases
Disease areas
Focus on severe and chronic diseases
Developing treatments for diseases within the central nervous system, rare diseases, endocrinology, oncology and supportive care
Events
Upcoming events
-
08 May
Nordea Equities Health Care Seminar
Camurus’ President & CEO Fredrik Tiberg is presenting at this conference in Stockholm, 8 May, at 12.45 pm CET. The presentation can be seen by the conference participants.
-
15 May
Interim Report January-March 2025
The interim report January-March is published on 15 May 2025.
-
15 May
Interim Report January-March 2025 – Audiocast
Financial analysts and media are invited to attend a telephone conference and presentation of the first quarter results at 2.00 pm CET. Audiocast
Latest financial report
Camurus Annual Report for 2024
30 April 2025
Annual General Meeting
Camurus’ Annual General Meeting 2025 will be held on Tuesday, 27 May, 2025, at 17.00 CEST at The Loop, Rydbergs torg 4, in Lund, Sweden. Registration for the AGM begins at 16.30 CEST. Registration and/or digital postal voting is done via Euroclear:
https://anmalan.vpc.se/EuroclearProxy/
See Notice of annual general meeting 2025
See documents for annual general meeting 2025
See more information on Camurus’ general meetings
Pipeline
Diversified pipeline with large potential
Camurus’ innovative product candidates are designed to address important unmet medical needs, with the potential to make significant difference in the daily life of patients by improving treatment outcomes, quality of life, and long-term recovery.
sustainability
Sustainable solutions for a healthier world
Ensuring the long-term successful development of our business – for the benefit of patients, healthcare systems, employees and shareholders.
